- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07638488
Trigger Point Extracorporeal Shock Wave Therapy in Patients With Lateral Epicondylitis (LE-TP-ESWT)
The Effect of Extracorporeal Shock Wave Therapy Applied to the Trigger Point on Grip Strength, Visual Analog Scale Score, and Common Extensor Tendon Thickness in Patients With Lateral Epicondylitis
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Lateral epicondylitis is a common tendinopathic condition characterized by pain over the lateral elbow, reduced grip strength, and limitation in upper extremity function. The extensor carpi radialis brevis tendon and the common extensor tendon origin are frequently involved. Myofascial trigger points in the extensor carpi radialis brevis muscle may also contribute to pain and functional impairment.
This prospective randomized controlled single-blind study investigates whether extracorporeal shock wave therapy applied to the extensor carpi radialis brevis trigger point provides additional clinical and ultrasonographic benefit in patients with lateral epicondylitis. Participants are allocated to two parallel groups. Both groups receive active extracorporeal shock wave therapy to the lateral epicondyle region once weekly for three sessions. The intervention group also receives active extracorporeal shock wave therapy to one trigger point in the extensor carpi radialis brevis muscle. The comparator group receives sham extracorporeal shock wave therapy to the same trigger point area.
Outcome assessments are performed at baseline and at week 4. Pain intensity is assessed using the Visual Analog Scale. Grip strength is measured with a Jamar hand dynamometer. Hand function is assessed using the Duruöz Hand Index. Common extensor tendon thickness is measured by ultrasonography. The primary aim is to determine whether active trigger point extracorporeal shock wave therapy provides additional improvement compared with sham trigger point application when both groups receive active treatment to the lateral epicondyle region.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Ankara
-
Ankara, Ankara, Turquía (Türkiye), 06560
- Gazi University Faculty of Medicine Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Age between 18 and 50 years
- Clinical diagnosis of lateral epicondylitis
- Tenderness over the lateral epicondyle
- Presence of trigger point in the extensor carpi radialis brevis muscle
- Ability to provide written informed consent
Exclusion Criteria:
- Peripheral nerve disease involving the ulnar, median, or radial nerve
- Other elbow pathologies such as instability, arthritis, or dermatologic lesions
- Radicular pain
- Previous elbow surgery
- Platelet-rich plasma injection, stem cell injection, corticosteroid injection, or extracorporeal shock wave therapy to the affected elbow within the previous month
- Presence of a pacemaker
- Pregnancy
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Active Trigger Point ESWT Group
Participants receive active extracorporeal shock wave therapy to the lateral epicondyle region and active extracorporeal shock wave therapy to one trigger point in the extensor carpi radialis brevis muscle, once weekly for three sessions.
|
Active extracorporeal shock wave therapy is applied to the lateral epicondyle region in both groups once weekly for three sessions.
In the experimental group, active extracorporeal shock wave therapy is also applied to one trigger point in the extensor carpi radialis brevis muscle.
|
|
Comparador falso: Sham Trigger Point ESWT Group
Participants receive active extracorporeal shock wave therapy to the lateral epicondyle region and sham extracorporeal shock wave therapy to one trigger point in the extensor carpi radialis brevis muscle, once weekly for three sessions.
|
Active extracorporeal shock wave therapy is applied to the lateral epicondyle region in both groups once weekly for three sessions.
In the experimental group, active extracorporeal shock wave therapy is also applied to one trigger point in the extensor carpi radialis brevis muscle.
Sham extracorporeal shock wave therapy is applied to one trigger point in the extensor carpi radialis brevis muscle using a sham applicator that produces a similar sound but does not deliver therapeutic shock wave energy.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Common Extensor Tendon Thickness
Periodo de tiempo: Baseline and week 4
|
Common extensor tendon thickness is measured by ultrasonography using a linear probe with the elbow flexed at 90 degrees and the forearm in mid-supination.
Measurements are performed on a longitudinal image at the lateral epicondyle region, perpendicular to the tendon fibers.
The change from baseline to week 4 is evaluated
|
Baseline and week 4
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Pain Intensity Assessed by Visual Analog Scale
Periodo de tiempo: Baseline and week 4
|
Pain intensity is assessed using a 10-cm Visual Analog Scale.
A score of 0 indicates no pain and a score of 10 indicates the worst pain.
|
Baseline and week 4
|
|
Change in Grip Strength
Periodo de tiempo: Baseline and week 4
|
Grip strength is measured using a Jamar hand dynamometer.
Measurements are performed with the participant seated, the shoulder adducted, the elbow flexed at 90 degrees, the forearm in neutral position, and the wrist in neutral position.
Three consecutive measurements are obtained from the affected side, and the mean value is used for analysis.
The change from baseline to week 4 is evaluated.
|
Baseline and week 4
|
|
Change in Functional Disability Assessed by the Duruöz Hand Index
Periodo de tiempo: Baseline and week 4
|
functional disability is assessed using the Duruöz Hand Index.
The scale includes 18 items evaluating difficulties in daily activities involving hand use.
Total scores range from 0 to 90, with higher scores indicating greater disability.
The change from baseline to week 4 is evaluated.
|
Baseline and week 4
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Tendinopatía de codo
- Lesiones de codo
- Enfermedades musculoesqueléticas
- Enfermedades Musculares
- Heridas y Lesiones
- Lesiones de tendones
- Lesiones en el brazo
- Tendinopatía
- Codo de tenista
- Terapéutica
- Modalidades de fisioterapia
- Rehabilitación
- Terapia ultrasónica
- Diatermia
- Hipertermia, inducida
- Terapia de ondas de choque extracorpóeos
Otros números de identificación del estudio
- LE-ESWT-ECRB-2026
- KD24/04 (Otro identificador: Başkent University Clinical Research Ethics Committee)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .